Death causes in breast cancer patients

被引:109
作者
Riihimaeki, M. [1 ,2 ]
Thomsen, H. [1 ]
Brandt, A. [1 ]
Sundquist, J. [2 ,3 ]
Hemminki, K. [1 ,2 ]
机构
[1] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
[2] Lund Univ, Ctr Primary Care Res, Malmo, Sweden
[3] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
关键词
breast cancer; cause of death; comorbidity; regression analysis; BIG; 1-98; TRIAL; POSTMENOPAUSAL WOMEN; COMPETING CAUSES; FOLLOW-UP; MORTALITY; RADIOTHERAPY; TAMOXIFEN; COMORBIDITY; RISK; CHEMOTHERAPY;
D O I
10.1093/annonc/mdr160
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Due to improved outcomes in breast cancer (BCa), the proportion of affected women dying of other causes has increased. Thus, a better survival of BCa requires knowledge of other causes of death. Materials and methods: Data on the population, cancers, and causes of death were gathered from the nationwide Swedish Family-Cancer Database, enrolling similar to 3.68 million Swedish women. A Cox regression model, comparing BCa patients against all other women, was applied. Cause-of-death-specific hazard ratios (HRs) were calculated for both underlying and multiple causes of death. Results: Among 641 000 deaths from 1987 to 2006, 48 000 were BCa patients. For underlying causes except BCa, the highest cause-specific HRs were found for diseases of pulmonary circulation {1.51 [95% confidence interval (CI) 1.36-1.68]}, suicide [1.39 (1.19-1.63)], and heart failure [1.29 (1.22-1.37)]. For specific multiple causes, the highest ratios were found for external causes [1.86 (1.80-1.91)] and gastrointestinal disease [1.68 (1.62-1.74)]. Conclusions: Diagnosis of BCa is associated with increased risks of dying of various causes, including external causes, heart failure, diseases of pulmonary circulation, and gastrointestinal disease. The study fulfills the gap in knowledge of death causes in BCa patients and suggests to draw more attention to comorbidities.
引用
收藏
页码:604 / +
页数:7
相关论文
共 42 条
[1]  
[Anonymous], 2004, INT STAT CLASS DIS R
[2]   Non-cancer mortality among people diagnosed with cancer (Australia) [J].
Baade, PD ;
Fritschi, L ;
Eakin, EG .
CANCER CAUSES & CONTROL, 2006, 17 (03) :287-297
[3]   Breast cancer incidence and mortality trends in 16 European countries [J].
Botha, JL ;
Bray, F ;
Sankila, R ;
Parkin, DM .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) :1718-1729
[4]   The hypercoagulable state of malignancy: Pathogenesis and current debate [J].
Caine, GJ ;
Stonelake, PS ;
Lip, GYH ;
Kehoe, ST .
NEOPLASIA, 2002, 4 (06) :465-473
[5]  
Carroll James, 2009, Clin Colon Rectal Surg, V22, P47, DOI 10.1055/s-0029-1202886
[6]   Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer [J].
Chapman, Judith-Anne W. ;
Meng, Daniel ;
Shepherd, Lois ;
Parulekar, Wendy ;
Ingle, James N. ;
Muss, Hyman B. ;
Palmer, Michael ;
Yu, Changhong ;
Goss, Paul E. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (04) :252-260
[7]   Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer:: The BIG 1-98 trial [J].
Crivellari, Diana ;
Sun, Zhuoxin ;
Coates, Alan S. ;
Price, Karen N. ;
Thuerlimann, Beat ;
Mouridsen, Henning ;
Mauriac, Louis ;
Forbes, John F. ;
Paridaens, Robert J. ;
Castiglione-Gertsch, Monica ;
Gelber, Richard D. ;
Colleoni, Marco ;
Lang, Istvan ;
Del Mastro, Lucia ;
Gladieff, Laurence ;
Rabaglio, Manuela ;
Smith, Ian E. ;
Chirgwin, Jacquie H. ;
Goldhirsch, Aron .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) :1972-1979
[8]   Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial [J].
Cuzick, Jack ;
Forbes, John F. ;
Sestak, Ivana ;
Cawthorn, Simon ;
Hamed, Hisham ;
Holli, Kaija ;
Howell, Anthony .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (04) :272-282
[9]   Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women [J].
Darby, S ;
McGale, P ;
Peto, R ;
Granath, F ;
Hall, P ;
Ekbom, A .
BRITISH MEDICAL JOURNAL, 2003, 326 (7383) :256-257
[10]   Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries [J].
Darby, SC ;
McGale, P ;
Taylor, CW ;
Peto, R .
LANCET ONCOLOGY, 2005, 6 (08) :557-565